1. Introduction
Reproductive efficiency in ruminants serves as a critical indicator for both economic viability and sustainable development in animal husbandry [
1,
2]. Studies report that despite optimal herd management, high rates of pregnancy loss persist in both sheep and cattle populations, representing a major constraint on reproductive efficiency [
1,
3]. Placental development during gestation significantly impacts ovine reproductive performance. As a unique exchange organ between dam and fetus originating from extraembryonic tissues, the placenta fulfills multiple essential functions throughout pregnancy, including facilitating maternal physiological adaptation, regulating fetal immune acceptance, and providing nutritional support [
4,
5]. Protein expression patterns in the placenta demonstrate marked dynamic changes during gestation, reflecting cellular and tissue-level functional adaptations [
5]. Given proteins’ central role in biological processes, investigating gestational stage-specific protein expression differences in ovine placenta could reveal molecular mechanisms underlying placental development and adaptive responses.
Hu sheep, valued for their year-round estrus, high fecundity, and adaptability to intensive housing, are China’s predominant maternal breed in meat sheep production systems [
6]. Elucidating the molecular genetic mechanisms underlying Hu sheep’s prolificacy holds significant importance. Previous research has predominantly focused on placental morphological and histological characteristics, with limited exploration of dynamic proteomic changes during gestation [
7]. Advances in proteomic technologies now enable comprehensive profiling of placental protein expression, offering molecular insights into complex biochemical processes that complement genomic and transcriptomic studies [
8,
9]. During mid-to-late gestation, Hu sheep face substantial nutritional stress, elevating scientific interest in placental function as the critical mediator of maternal–fetal nutrient exchange [
7]. Despite previous studies, a systematic characterization of temporal proteomic signatures in the ovine placenta across developmental stages is lacking. Investigating stage-specific placental protein expression could unravel physiological adaptations in pregnancy, informing strategies to enhance reproductive efficiency. Understanding these regulatory mechanisms may optimize breeding management practices, potentially improving conception rates and lamb survival outcomes.
Therefore, this study investigated Hu sheep placental samples collected after 50 d, 80 d, and 120 d of gestation using data-independent acquisition (DIA) proteomics combined with bioinformatics analysis. The experimental design systematically identified candidate differentially expressed proteins (DEPs) or target molecules associated with placental development, hormonal secretion, and nutrient transport functions in ovine placentas.
3. Discussion
The placenta functions as a dynamic endocrine organ, secreting numerous factors into maternal circulation to support fetal development. However, understanding placental development remains challenging due to limited access to early-stage placental tissues and the lack of reliable long-term in vitro or animal models [
10]. Ruminant placentation exhibits unique adaptations distinct from other mammals, initially developing a non-invasive epitheliochorial structure during early gestation, followed by binucleate trophoblast cell migration and fusion with uterine luminal epithelium to form syncytial plaques in sheep [
11]. This process facilitates placental attachment to endometrial caruncles, forming vascularized cotyledons critical for nutrient exchange [
1,
12]. While most studies focus on early gestation and embryo attachment, proteomic changes during mid-to-late placental development remain poorly characterized. Our study addressed this gap by employing data-independent acquisition (DIA) proteomics to analyze ovine placental cotyledons after 50, 80, and 120 days of gestation. The results demonstrated extensive proteome remodeling across developmental stages, with 1350 differentially expressed proteins (DEPs) identified between 50 and 80 days, 1026 DEPs between 80 and 120 days, and 1964 DEPs when comparing early (50 d) and late (120 d) gestation. These findings underscore the placenta’s dynamic molecular adaptations to meet evolving fetal nutritional demands during mid-to-late pregnancy.
The syncytiotrophoblast layer of the placenta serves as both a functional barrier and a critical interface for maternal–fetal nutrient exchange. This structure forms initially through the fusion of mononuclear cytotrophoblasts during implantation, with ongoing syncytialization throughout gestation to expand the surface area for nutrient transport [
13]. TJP-1 (tight junction protein 1) localizes to intercellular boundaries between cytotrophoblasts and syncytiotrophoblasts, playing a conserved role in placental development across species [
14]. In addition, there have been studies using gene knockout mouse models to determine the role of closure band proteins in early development [
15]. Studies in knockout mice demonstrate that TJP-1 deficiency disrupts placental vascularization and chorioallantoic fusion [
16], aligning with our findings of progressive TJP-1 upregulation in ovine placental cotyledons across gestation. Our proteomic analysis revealed increasing enrichment of tight junction pathway components in placental DEPs as pregnancy advanced. The rising TJP-1 expression likely reflects adaptive mechanisms to modulate vascular permeability and enhance nutrient transport efficiency [
14,
17], paralleled by sustained increases in CLDN7 and CLDN8—claudin family proteins that regulate paracellular permeability [
18]. These proteins interact with TJP-1 to scaffold diverse junctional complexes [
19], inversely correlating with tissue permeability [
20]. Tight junction dynamics are hormonally modulated by progesterone, prolactin, and placental lactogens [
21], with calcium signaling and kinase pathways further fine-tuning paracellular transport [
22]. The coordinated upregulation of these components suggests a concerted effort to optimize placental barrier function during late gestation.
The placenta profoundly modifies maternal metabolism by secreting substantial quantities of hormones into maternal circulation [
23], extending beyond its primary role in fetal nourishment. These placental-derived hormones orchestrate systemic maternal adaptations by regulating most maternal tissues and organs, thereby facilitating the maintenance of pregnancy, nutrient mobilization, parturition, and lactation. Concurrently, certain placental hormones are released into fetal circulation to regulate developmental processes, growth trajectories, and parturition timing [
24,
25]. Our findings align with previous reports demonstrating that maternal serum estradiol and estriol levels progressively increase throughout gestation, peaking during late pregnancy [
26], while progesterone levels rapidly rise during early pregnancy and plateau mid-gestation before further increasing in late gestation [
27]. The significant enrichment of differential proteins in steroid biosynthesis pathways during the 80–120 d gestational phase, as observed in our study, likely reflects the placenta’s intensified hormone production in late gestation, which serves as the principal source of maternal estrogens and progesterone [
27]. These steroid hormones exhibit complementary regulatory functions: estrogens stimulate uterine expansion, enhance myometrial contractility, and promote mammary gland development, whereas progesterone suppresses premature uterine contractions and facilitates placental maturation while mitigating preterm labor risks [
28].
Our study identified significant upregulation of key ERK/MAPK pathway components—NRAS, KRAS, and MAP3K1—during 50–80 d and 50–120 d gestational intervals. In mammals, ERK/MAPK activation is initiated by growth factor–receptor interactions, particularly tyrosine kinase receptors for FGF, EGF, and VEGF [
29]. This pathway promotes trophoblast proliferation, survival, and establishment of the blood–placental barrier, which expands the exchange surface for nutrients and gases [
30].
Comparative proteomic profiling of ovine placental cotyledons revealed dynamic remodeling of junctional complexes across gestation. The tight junction proteins TJP-1, CLDN7, and CLDN8 exhibited progressive upregulation, reflecting functional adaptations to enhance selective barrier integrity and maternal–fetal exchange efficiency. These proteins govern paracellular permeability and cell–cell adhesion, with elevated expression likely optimizing nutrient transport capacity during late gestation [
18,
19]. The coordinated regulation of ERK/MAPK signaling and junctional components underscores multifaceted mechanisms driving placental maturation to meet escalating fetal demands.
This study identified distinct proteomic profiles in ovine placental cotyledons across gestational stages, with differential expression of key proteins including TJP-1, CLDN7, CLDN8, KRAS, NRAS, and MAP3K1. KRAS and NRAS, critical members of the Ras family, and MAP3K1—an upstream regulator of the MAPK signaling cascade—exhibited stage-specific abundance changes. These proteins modulate cellular proliferation, differentiation, and apoptosis, suggesting their dynamic expression may be closely associated with placental growth and functional remodeling [
29,
30].
The progressive upregulation of TJP-1, CLDN7, and CLDN8 across gestation aligns with their roles in maintaining tight junction integrity and regulating paracellular permeability [
18,
19]. Such adaptations likely enhance nutrient transport efficiency while balancing barrier selectivity, as evidenced by concurrent ERK/MAPK pathway activation and vascularization-related protein shifts [
17]. Furthermore, stage-specific alterations in signal transduction proteins highlight the placenta’s capacity to dynamically integrate hormonal and growth factor cues [
21,
22].
5. Materials and Methods
5.1. Experimental Animals and Tissue Collection
All experimental Hu sheep were obtained from Qianbao Animal Husbandry Co., Ltd. (Yancheng, China). High-prolificacy Hu sheep (2–3 years old, producing ≥3 lambs per parity consecutively over two pregnancies) were selected based on pedigree records. Following a synchronized estrus protocol, placental chorionic trophoblast tissues were aseptically collected at 50 d, 80 d, and 120 d of gestation (n = 3 per timepoint). Samples were immediately flash-frozen in liquid nitrogen (−196 °C) and stored at −80 °C. The experimental protocol was approved by the Nanjing Agricultural University Animal Welfare Ethics Committee (Approval No.: SYXK2022-0031).
5.2. Protein Extraction and Digestion
Procedures followed Zhang et al. [
31] with modifications. Briefly, tissues were homogenized in lysis buffer (containing SDS, urea, and protease inhibitors). Homogenates were centrifuged at 12,000×
g for 15 min at 4 °C, and supernatants were quantified using a BCA assay. Proteins were reduced with 10 mM DTT (56 °C, 30 min), alkylated with 55 mM iodoacetamide (25 °C, 30 min, dark), and precipitated overnight with pre-chilled acetone (−20 °C). Precipitates were washed twice with cold acetone, air-dried, and digested with sequencing-grade trypsin (1:50
w/
w, 37 °C, 16 h).
5.3. High-pH Liquid Chromatography Fractionation
The liquid chromatography system (UltiMate 3000, Thermo Fisher Scientific, Waltham, MA, USA) was interfaced with a timsTOF Pro2 mass spectrometer (Bruker Daltonics, Bremen, Germany) featuring ion mobility spectrometry–quadrupole time-of-flight (IMS-Q-TOF) technology. Chromatographic separation was performed using an Aurora Series AUR3-15075C18 column (IonOpticks, 15 cm × 75 μm ID, 1.7 μm particles, 120 Å pores) maintained at 50 °C with a constant flow rate of 400 nL/min. Following reconstitution in 0.1% formic acid (FA), 200 ng peptide samples were separated using a 60-min nonlinear gradient: the initial 4% mobile phase B (80% acetonitrile/0.1% FA) was increased to 28% over 25 min, followed by 44% in 10 min, 90% in 10 min (maintained for 7 min), and finally re-equilibrated at 4% for 8 min.
Data-independent acquisition (DIA) was conducted in diaPASEF mode with 22 precursor isolation windows (40 Th each) spanning m/z 349-1229. To optimize MS1 cycle time, we implemented a variable repetition scheme (2–5 steps) within the 13-scan diaPASEF acquisition framework. Collision energy during PASEF MS/MS scanning was linearly modulated based on ion mobility (1/K0), decreasing from 59 eV at 1.6 Vs/cm2 to 20 eV at 0.6 Vs/cm2.
5.4. DIA: Nano-HPLC-MS/MS Analysis
Dried peptide samples were redissolved in 30 μL of solvent A (0.1% aqueous formic acid) and subjected to in-depth analysis using an online nano-electrospray liquid chromatography–tandem mass spectrometry (nano-LC-MS/MS) system on an Orbitrap Fusion Lumos Tribrid mass spectrometer. The EASY nLC 1200 ultra-high-performance liquid chromatography system was integrated to ensure analytical precision. During the experiment, 3 μL of sample was loaded onto the analytical column. A 120-min gradient elution program was applied, gradually increasing the concentration of buffer B (0.1% formic acid in acetonitrile) from 5% to 35% to effectively separate peptides. Throughout the analysis, the column temperature was maintained at 40 °C with a constant flow rate of 200 nL/min. Ionization was achieved using a 2 kV electrospray voltage relative to the mass spectrometer inlet. The instrument operated in data-independent acquisition (DIA) mode, automatically alternating between full mass spectrometry (MS) and tandem mass spectrometry (MS/MS) modes to enhance analytical comprehensiveness and depth.
The protein qualitative criteria were as follows: precursor threshold 1.0%, FDR; protein threshold, 1.0% FDR. The decoy database was generated using the mutated strategy, which is similar to the shuffled sequence of a random number of amino acids (minimum 2 amino acids, maximum half of the total length of the peptide). Spectronaut performed automatic correction and used a local normalization strategy for data normalization. MaxLFQ was used for protein group quantification for peptides less than 1.0% FDR.
The source of the protein data bank is the Ensembl database (
https://asia.ensembl.org/index.html), the use version is Ensembl_release110, and the download date is 28 February 2024.
5.5. Bioinformatics Analysis
The workflow leveraged Spectronaut 18 as the core software for DIA data processing, with stringent FDR control (1% at feature levels), dynamic mass time calibration, and MaxLFQ-based quantification. Static (carbamidomethylation) and dynamic (oxidation) modifications were explicitly defined, while mass error tolerance was dynamically optimized using iRT peptides. Downstream analyses employed R packages for statistical testing (5% FDR for DEPs) and bioinformatics tools (Pfam_scan) for functional annotation. All software settings adhered to community standards for reproducibility and analytical rigor in DIA proteomics.
Bioinformatics methods were employed to analyze significantly differential proteins in Hu sheep placentas across gestational stages. First, Gene Ontology (GO) database annotations classified these proteins into biological processes, molecular functions, and cellular components. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis then identified functionally enriched pathways and genomic interactions critical to placental development (significance thresholds: p < 0.05, FDR Q < 0.05). For data visualization, the R programming language and OmicShare online platform (Guangzhou Gidio Biotech, Guangzhou, China) generated heatmaps, enrichment bubble plots, volcano plots, and Venn diagrams. Protein–protein interaction (PPI) networks were constructed using the STRING v11.5 database and visualized via Cytoscape 3.7.1 to elucidate regulatory relationships among differential proteins during placental maturation.
5.6. Quantitative Real-Time PCR (qRT-PCR)
Total RNA was extracted from placental tissues using Trizol reagent (TaKaRa Bio Inc., Shiga, Japan, CAS: 9108). Frozen placental samples (0.1 g) were homogenized in sterile, nuclease-free grinding tubes with 1 mL of pre-chilled Trizol reagent and stainless-steel beads. After incubation at room temperature for 5 min, homogenates were centrifuged at 12,000× g for 5 min (4 °C). The supernatant was transferred to a new 1.5 mL EP tube, mixed with 200 μL chloroform by vigorous vortexing for 15 s, and incubated on ice for 5 min before centrifugation at 12,000× g for 15 min (4 °C). A 400 μL aliquot of the aqueous phase was combined with an equal volume of chilled isopropanol, inverted 15 times, and incubated on ice for 10 min. RNA pellets were collected by centrifugation at 12,000× g for 10 min (4 °C), washed twice with 75% ethanol (12,000× g, 5 min, 4 °C), and air-dried in a laminar flow hood. RNA was dissolved in RNase-free water and quantified using a Thermo NanoDrop 2000 spectrophotometer (Thermo Scientific, Waltham, MA, USA). RNA integrity was verified by 1.5% agarose gel electrophoresis, with intact RNA exhibiting a 28S:18S ribosomal RNA band intensity ratio of ~2:1 under UV visualization.
For cDNA synthesis, RNA was diluted to 500 ng/μL in nuclease-free water. Reverse transcription was performed using the PrimeScript RT reagent kit (Accurate Biotechnology, Changsha, China Cat NO. AG11728) according to the manufacturer’s protocol. Synthesized cDNA was stored at −20 °C for subsequent qRT-PCR analysis. The primers and amplicon sizes of the genes are shown in
Table S1.
5.7. Protein Extraction and Western Blot
Total tissue proteins were extracted using a reagent mixture of RIPA lysis buffer, PMSF, and phosphatase inhibitors in a 100:1:1 ratio (v/v/v). Protein concentrations were quantified using a BCA Protein Assay Kit (Beyotime Biotechnology, Beijing, China, Cat. #P0010) according to the manufacturer’s instructions. Samples were diluted to 1 μg/μL, mixed with 20 μL of 5× SDS-PAGE loading buffer, adjusted to a final volume of 100 μL with RNase-free water, and denatured at 100 °C for 5 min.
For Western blot analysis, proteins were separated by SDS-PAGE at 150 V for 45 min and transferred to PVDF membranes at 300 V for 45 min. Membranes were blocked with 5% non-fat milk in TBST buffer for 2 h to minimize nonspecific binding. Primary antibodies (
Table S2) (5% dilution in blocking buffer) were incubated with the membranes at 4 °C for 12–16 h, followed by three 10 min TBST washes. Horseradish peroxidase (HRP)-conjugated secondary antibodies (5% dilution in 5% non-fat milk/TBST) were applied for 1 h at room temperature, with subsequent TBST washes. Membranes were incubated in ECL reagent for 1 min and imaged using a high-sensitivity chemiluminescence detection system. Band intensities were quantified using ImageJ v. 1.53t software to assess target protein expression levels.
5.8. Statistical Analysis
All experimental results are presented as mean ± standard error of the mean (SEM). Data were subjected to one-way analysis of variance (ANOVA) using SPSS software (version 24.0, IBM Corporation, Armonk, NY, USA). Significance thresholds were defined as follows: p < 0.05 (significant) and * p < 0.01 (highly significant).
Protein differential expression was statistically evaluated using a two-tailed Student’s t-test with Benjamini–Hochberg false discovery rate (FDR) correction. Significant candidates were identified through dual-threshold filtering: (1) magnitude thresholds of >1.2-fold upregulation or <0.83-fold downregulation (log2 ratio >0.26 or <−0.26) and (2) significance threshold of FDR-adjusted p-value < 0.05.